Evidence map›Paper›PMID 24713787›Full record

ReviewAnnals of gastroenterology2011

Recent advances in diagnosis and treatment of microscopic colitis.

Curt Tysk, Anna Wickbom, Nils Nyhlin, Sune Eriksson, Johan Bohr

Open access · greenAbstract readReview
In one paragraph

Review in Annals of gastroenterology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
8.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Optimal management of collagenous colitis: a review.Clinical and experimental gastroenterology · 2016
    Review
  9. Article
  10. Article
  11. Observational
  12. Diagnosis and management of microscopic colitis: current perspectives.Clinical and experimental gastroenterology · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Curt TyskDepartment of Medicine, Division of Gastroenterology, Örebro University Hospital and School of Health and Medical Sciences,Örebro University, Örebro, Sweden (Curt Tysk, Anna Wickbom, Nils Nyhlin, Johan Bohr).
Anna WickbomDepartment of Medicine, Division of Gastroenterology, Örebro University Hospital and School of Health and Medical Sciences,Örebro University, Örebro, Sweden (Curt Tysk, Anna Wickbom, Nils Nyhlin, Johan Bohr).
Nils NyhlinDepartment of Medicine, Division of Gastroenterology, Örebro University Hospital and School of Health and Medical Sciences,Örebro University, Örebro, Sweden (Curt Tysk, Anna Wickbom, Nils Nyhlin, Johan Bohr).
Sune ErikssonDepartment of LaboratoryMedicine, Division of Pathology, Örebro University Hospital,Örebro, Sweden (Sune Eriksson).
Johan BohrDepartment of Medicine, Division of Gastroenterology, Örebro University Hospital and School of Health and Medical Sciences,Örebro University, Örebro, Sweden (Curt Tysk, Anna Wickbom, Nils Nyhlin, Johan Bohr).
Örebro University · SEÖrebro University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microscopic colitis, comprising collagenous colitis and lymphocytic colitis, is a common cause of chronic diarrhea. It is characterized clinically by chronic watery diarrhea and a macroscopically normal colonic mucosa where diagnostic histopathological features are seen on microscopic examination. The annual incidence of each disorder is 4-6/100,000 inhabitants, with a peak incidence in individuals 60-70 years old and a noticeable female predominance in collagenous colitis. The etiology is unknown. Chronic diarrhea, abdominal pain, weight loss, fatigue, and fecal incontinence are common symptoms that impair the health-related quality of life of the patient. There is an association with other autoimmune disorders, such as celiac disease, thyroid disorders, diabetes mellitus, and arthritis. Budesonide is the best-documented treatment, both short-term and long-term. Recurrence of symptoms is common after withdrawal of successful budesonide therapy, and the optimal long-term treatment strategy needs further study. The long-term prognosis is good, and the risk of complications including colon cancer is low. We review the epidemiology, clinical features, diagnosis and treatment of microscopic colitis.

Indexed as

budesonidechronic diarrheacollagenous colitislymphocytic colitisMicroscopic colitis

Identifiers

PMID24713787
PMCPMC3959332
OpenAlexW2150636440

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.